Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshifumi Yokota

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Expert Reviews in Molecular Medicine|October 3, 2019
Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophiesJaeho Hwang, Toshifumi Yokota
International Journal of Molecular Sciences|February 15, 2022
CRISPR Therapeutics for Duchenne Muscular DystrophyEsra Erkut, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Rapid Freezing of Skeletal and Cardiac Muscles Using Isopentane Cooled with Liquid Nitrogen and Tragacanth Gum for Histological, Genetic, and Protein Expression StudiesSaeed Anwar, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding AssaySaeed Anwar, Toshifumi Yokota
Genes|December 23, 2023
Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic FrontiersSaeed Anwar, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2023
In Vivo Evaluation of Exon 51 Skipping in hDMD/Dmd-null MiceNarin Sheri, Toshifumi Yokota
Bioanalysis|September 22, 2025
Upgrading nucleic acid and antisense therapeutics: challenges, solutions, and future directionsAbdullah Zia, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Progress and Future Directions in Exon Skipping and Inclusion Therapies: The Landscape of Oligonucleotide-Based Genetic MedicineSaeed Anwar, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon InclusionRika Maruyama, Toshifumi Yokota
Genes|July 29, 2025
Brogidirsen and Exon 44 Skipping for Duchenne Muscular Dystrophy: Advances and Challenges in RNA-Based TherapyAnnie Tang, Toshifumi Yokota
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Expert Reviews in Molecular Medicine|October 3, 2019
Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophiesJaeho Hwang, Toshifumi Yokota
International Journal of Molecular Sciences|February 15, 2022
CRISPR Therapeutics for Duchenne Muscular DystrophyEsra Erkut, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Rapid Freezing of Skeletal and Cardiac Muscles Using Isopentane Cooled with Liquid Nitrogen and Tragacanth Gum for Histological, Genetic, and Protein Expression StudiesSaeed Anwar, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding AssaySaeed Anwar, Toshifumi Yokota
Genes|December 23, 2023
Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic FrontiersSaeed Anwar, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2023
In Vivo Evaluation of Exon 51 Skipping in hDMD/Dmd-null MiceNarin Sheri, Toshifumi Yokota
Bioanalysis|September 22, 2025
Upgrading nucleic acid and antisense therapeutics: challenges, solutions, and future directionsAbdullah Zia, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Progress and Future Directions in Exon Skipping and Inclusion Therapies: The Landscape of Oligonucleotide-Based Genetic MedicineSaeed Anwar, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon InclusionRika Maruyama, Toshifumi Yokota
Genes|July 29, 2025
Brogidirsen and Exon 44 Skipping for Duchenne Muscular Dystrophy: Advances and Challenges in RNA-Based TherapyAnnie Tang, Toshifumi Yokota
Pageof 19